49.92

1.46% 0.72

Prestige Consumer Healthcare Inc (PBH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$49.20

Offen:

$49.48

24-Stunden-Volumen:

580.63K

Relative Volume:

1.09

Marktkapitalisierung:

$2.36B

Einnahmen:

$1.10B

Nettoeinkommen (Verlust:

$186.50M

KGV:

13.20

EPS:

3.7817

Netto-Cashflow:

$267.19M

1W Leistung:

+3.50%

1M Leistung:

+6.53%

6M Leistung:

-12.50%

1J Leistung:

-19.24%

1-Tages-Spanne:

$49.28

$50.27

1-Wochen-Bereich:

$47.80

$50.84

52-Wochen-Spanne:

$42.62

$71.07

Prestige Consumer Healthcare Inc Stock (PBH) Company Profile

Firmenname

Prestige Consumer Healthcare Inc

Sektor

Healthcare (1052)

Branche

Drug Manufacturers - Specialty & Generic (84)

Telefon

(914) 524-6800

Adresse

660 WHITE PLAINS RD., TARRYTOWN, NY

Mitarbeiter

890

Twitter

Nächster Verdiensttermin

2026-11-05

Neueste SEC-Einreichungen

PBH's Discussions on Twitter

Compare PBH vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PBH Prestige Consumer Healthcare Inc	49.92	2.36B	1.10B	186.50M	267.19M	3.7817
TAK Takeda Pharmaceutical Co Adr	19.67	62.84B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	41.50	48.40B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	10.13	44.55B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	79.38	32.80B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	533.12	22.87B	3.17B	1.29B	1.01B	27.09

Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-05-14	Herabstufung	Oppenheimer	Outperform → Perform
2025-09-24	Hochstufung	Sidoti	Neutral → Buy
2024-12-09	Herabstufung	Sidoti	Buy → Neutral
2024-06-21	Hochstufung	DA Davidson	Neutral → Buy
2022-11-17	Eingeleitet	Canaccord Genuity	Buy
2022-05-10	Hochstufung	Jefferies	Hold → Buy
2022-05-09	Hochstufung	Oppenheimer	Perform → Outperform
2020-08-07	Herabstufung	DA Davidson	Buy → Neutral
2020-06-29	Hochstufung	Sidoti	Neutral → Buy
2020-04-14	Herabstufung	Jefferies	Buy → Hold
2020-04-07	Fortgesetzt	Sidoti	Neutral
2020-03-26	Hochstufung	Jefferies	Hold → Buy
2020-03-24	Eingeleitet	Oppenheimer	Perform
2020-03-19	Hochstufung	DA Davidson	Neutral → Buy
2019-01-15	Herabstufung	Raymond James	Outperform → Mkt Perform
2017-12-04	Hochstufung	William Blair	Mkt Perform → Outperform
2017-06-02	Hochstufung	Jefferies	Underperform → Hold
2017-05-22	Hochstufung	Raymond James	Mkt Perform → Outperform
2016-12-27	Bestätigt	B. Riley & Co.	Buy
2016-11-17	Eingeleitet	Gabelli & Co	Buy
2016-08-12	Hochstufung	Sidoti	Neutral → Buy
2016-03-08	Eingeleitet	KeyBanc Capital Mkts	Overweight
2016-02-05	Eingeleitet	Piper Jaffray	Overweight
2015-11-30	Herabstufung	Jefferies	Hold → Underperform
2014-04-28	Bestätigt	B. Riley & Co.	Buy
2014-04-28	Bestätigt	Oppenheimer	Outperform
2013-07-09	Eingeleitet	B. Riley & Co.	Buy

Alle ansehen

Prestige Consumer Healthcare Inc Aktie (PBH) Neueste Nachrichten

Oct 15, 2026

Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now? - Zacks Investment Research

Oct 15, 2026

Oct 14, 2026

Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results - Yahoo Finance

Oct 14, 2026

How InvestingPro spotted Prestige Healthcare’s 43% stock decline By Investing.com - Investing.com

Oct 14, 2026

Oct 09, 2026

Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis $PBH - MarketBeat

Oct 09, 2026

Oct 08, 2026

What Does the Guidance Raise Mean for Prestige Consumer (NYSE:PBH)? - Kalkine Media

Oct 08, 2026

Oct 07, 2026

Prestige Consumer Healthcare stock falls 11% on Q4 revenue decline - scanx.trade

Oct 07, 2026

Prestige Consumer Q1FY27 Results: Revenue rises 6.5% to $266 million - scanx.trade

Oct 07, 2026

Transcript: Prestige Consumer Q1 2027 Earnings Conference Call - Benzinga

Oct 07, 2026

Prestige Consumer Latest Results: Sales guidance rises to $1.29B-$1.315B - scanx.trade

Oct 07, 2026

PBH vs. NEOG: Which Stock Is the Better Value Option? - Zacks Investment Research

Sep 30, 2026

More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds – Company AnnouncementFT.com - Financial Times

Sep 30, 2026

More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds – Company AnnouncementFT.com - Financial Times

Sep 30, 2026

Sep 29, 2026

Has Prestige Consumer Healthcare (PBH) Fallen Far Enough On Earnings? - Yahoo Finance

Sep 29, 2026

Sep 28, 2026

Prestige Consumer Healthcare (PBH) Could Be 30% Undervalued After Its 2027 Targets - Yahoo Finance

Sep 28, 2026

Sep 27, 2026

Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow - Yahoo Finance

Sep 27, 2026

Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow - TradingView

Sep 27, 2026

Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow - TradingView

Sep 27, 2026

Sep 24, 2026

Prestige Consumer Healthcare at small-cap virtual conference: growth plan intact - Investing.com India

Sep 24, 2026

Prestige Consumer Healthcare at small-cap virtual conference: growth plan intact - Investing.com

Sep 24, 2026

Sep 23, 2026

A Look at Prestige Consumer Healthcare Inc (PBH) After 3.8% Decl - GuruFocus

Sep 23, 2026